The global Aurora Kinase A market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Aurora Kinase A volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aurora Kinase A market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Aurora Kinase A in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Aurora Kinase A manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others

Segment by Application
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others